Literature DB >> 8253715

Synthesis and hydrolysis of cyclic ADP-ribose by human leukocyte antigen CD38 and inhibition of the hydrolysis by ATP.

S Takasawa1, A Tohgo, N Noguchi, T Koguma, K Nata, T Sugimoto, H Yonekura, H Okamoto.   

Abstract

Cyclic ADP-ribose (cADPR) has been recently shown to be generated in pancreatic beta-cells by glucose stimulation, serving as a second messenger for Ca2+ mobilization in the endoplasmic reticulum in the process of insulin secretion (Takasawa, S., Nata, K., Yonekura, H., and Okamoto, H. (1993) Science 259, 370-373). In the present study, we isolated a cDNA for CD38, which has been reported to be a human leukocyte antigen, from a human insulinoma and expressed the cDNA in COS-7 cells. CD38 expression was observed in the plasma membrane and the microsome fractions of the COS-7 cells. When we incubated the plasma membrane fraction with NAD+ and analyzed the reaction products by high pressure liquid chromatography, the formation of cADPR was observed in addition to the ADP-ribose (ADPR) formation. When the plasma membrane fraction was incubated with cADPR, cADPR was converted to ADPR stoichiometrically. These results suggest that CD38 has both cADPR-forming and -hydrolyzing activities. Moreover, we found that ATP (2-10 mM), generated in the glucose metabolism in beta-cells, inhibited the cADPR-hydrolyzing activity, resulting in the increased formation of cADPR. These findings indicate a role for CD38 in the synthesis and hydrolysis of cADPR in the process of insulin secretion in pancreatic beta-cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8253715

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Anti-CD38 autoimmunity in patients with chronic autoimmune thyroiditis or Graves' disease.

Authors:  A Antonelli; P Fallahi; C Nesti; C Pupilli; P Marchetti; S Takasawa; H Okamoto; E Ferrannini
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

2.  An emerging role for NAADP-mediated Ca2+ signaling in the pancreatic β-cell.

Authors:  Abdelilah Arredouani; A Mark Evans; Jianjie Ma; John Parrington; Michael X Zhu; Antony Galione
Journal:  Islets       Date:  2010-09-01       Impact factor: 2.694

3.  Structure and enzymatic functions of human CD38.

Authors:  Hon Cheung Lee
Journal:  Mol Med       Date:  2006 Nov-Dec       Impact factor: 6.354

4.  Mechanism of cyclizing NAD to cyclic ADP-ribose by ADP-ribosyl cyclase and CD38.

Authors:  Richard Graeff; Qun Liu; Irina A Kriksunov; Masayo Kotaka; Norman Oppenheimer; Quan Hao; Hon Cheung Lee
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

5.  Identification of bovine liver mitochondrial NAD+ glycohydrolase as ADP-ribosyl cyclase.

Authors:  M Ziegler; D Jorcke; M Schweiger
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

6.  Identification of a major enzyme for the synthesis and hydrolysis of cyclic ADP-ribose in amphibian cells and evolutional conservation of the enzyme from human to invertebrate.

Authors:  Takayuki Ikeda; Shin Takasawa; Naoya Noguchi; Koji Nata; Akiyo Yamauchi; Iwao Takahashi; Takeo Yoshikawa; Akira Sugawara; Hideto Yonekura; Hiroshi Okamoto
Journal:  Mol Cell Biochem       Date:  2012-03-16       Impact factor: 3.396

7.  CD38 is the major enzyme responsible for synthesis of nicotinic acid-adenine dinucleotide phosphate in mammalian tissues.

Authors:  Eduardo N Chini; Claudia C S Chini; Ichiro Kato; Shin Takasawa; Hiroshi Okamoto
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

8.  Inhibition of the intrinsic NAD+ glycohydrolase activity of CD38 by carbocyclic NAD analogues.

Authors:  K A Wall; M Klis; J Kornet; D Coyle; J C Amé; M K Jacobson; J T Slama
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

Review 9.  Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule.

Authors:  Antonella Chillemi; Gianluca Zaccarello; Valeria Quarona; Manuela Ferracin; Chiara Ghimenti; Massimo Massaia; Alberto L Horenstein; Fabio Malavasi
Journal:  Mol Med       Date:  2013-05-20       Impact factor: 6.354

10.  Decreased ADP-ribosyl cyclase activity in peripheral blood mononuclear cells from diabetic patients with nephropathy.

Authors:  Michio Ohtsuji; Kunimasa Yagi; Miyuki Shintaku-Kubota; Yukiko Kojima-Koba; Naoko Ito; Masako Sugihara; Naoto Yamaaki; Daisuke Chujo; Atsushi Nohara; Yoshiyu Takeda; Junji Kobayashi; Masakazu Yamagishi; Haruhiro Higashida
Journal:  Exp Diabetes Res       Date:  2009-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.